Current evidence for an inherited genetic basis of childhood acute lymphoblastic leukemia

International Journal of Hematology

Volumn 97, Issue 1, 2013, Pages 3-19

  Urayama, Kevin Y ^a   Chokkalingam, Anand P ^b   Manabe, Atsushi ^c   Mizutani, Shuki ^d  

^a St Luke's Life Science Institute   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Childhood leukemia; Genetic susceptibility; Genome wide association study; Predisposition; Single nucleotide polymorphism

Indexed keywords

(S) 2 HYDROXY ACID OXIDASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; ERYTHROCYTE BAND 4.1 PROTEIN; PROTEIN P63;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHILDHOOD LEUKEMIA; CHROMOSOME 2; CHROMOSOME DELETION; DNA DAMAGE; DNA METHYLATION; DNA REPAIR; ENVIRONMENTAL FACTOR; EXCISION REPAIR; FOLATE METABOLISM; FOLIC ACID DEFICIENCY; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; INHERITANCE; LYMPHOID PROGENITOR CELL; META ANALYSIS (TOPIC); NONHUMAN; PROMYELOCYTIC LEUKEMIA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; XENOBIOTIC METABOLISM;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFANT; INFANT, NEWBORN; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 84872906608     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-012-1220-9     Document Type: Article

References (113)

1. Pui CH. Childhood leukemias. N Engl J Med. 1995;332:1618-30.
2. Smith M, Ries L, Gurney J, Ross J. Leukemia. In: Ries L, Smith M, Gurney J, et al., editors. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. Pub. No. 99-4649 ed. Bethesda, MD: National Cancer Institute, SEER Program; 1999. p 17-34.
3. Wiemels J. Perspectives on the causes of childhood leukemia. Chem Biol Interact. 2012;196:59-67.
4. Greaves MF, Wiemels J. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer. 2003;3:639-49. (Pubitemid 37328819)
5. Chokkalingam AP, Buffler PA. Genetic susceptibility to childhood leukaemia. Radiat Prot Dosimetry. 2008;132:119-29.
6. Enciso-Mora V, Hosking FJ, Sheridan E, Kinsey SE, Lightfoot T, Roman E, et al. Common genetic variation contributes significantly to the risk of childhood B-cell precursor acute lymphoblastic leukemia. Leukemia. 2012;26:2212-5.
7. Greaves MF, Maia AT, Wiemels JL, Ford AM. Leukemia in twins: lessons in natural history. Blood. 2003;102:2321-33. (Pubitemid 37193565)
8. Wall JD, Pritchard JK. Haplotype blocks and linkage disequilibrium in the human genome. Nat Rev Genet. 2003;4:587-97. (Pubitemid 36917501)
9. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JP, et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet. 2008;9:356-69. (Pubitemid 351556063)
10. Buffler PA, Kwan ML, Reynolds P, Urayama KY. Environmental and genetic risk factors for childhood leukemia: Appraising the evidence. Cancer Invest. 2005;23:60-75. (Pubitemid 40344201)
11. Karathanasis NV, Choumerianou DM, Kalmanti M. Gene polymorphisms in childhood ALL. Pediatr Blood Cancer. 2009;52:318-23.
12. Vijayakrishnan J, Houlston RS. Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: A systematic review and meta-analysis. Haematologica. 2010;95:1405-14.
13. Beuten J, Gelfond JA, Piwkham D, Pollock BH, Winick NJ, Collier AB 3rd, et al. Candidate gene association analysis of acute lymphoblastic leukemia identifies new susceptibility locus at 11p15 (LMO1). Carcinogenesis. 2011;32:1349-53.
14. Chang JS, Wiemels JL, Chokkalingam AP, Metayer C, Barcellos LF, Hansen HM, et al. Genetic polymorphisms in adaptive immunity genes and childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev. 2010;19:2152-63.
15. Chokkalingam AP, Bartley K, Wiemels JL, Metayer C, Barcellos LF, Hansen HM, et al. Haplotypes of DNA repair and cell cycle control genes, X-ray exposure, and risk of childhood acute lymphoblastic leukemia. Cancer Causes Control. 2011;22:1721-30.
16. Chokkalingam AP, Metayer C, Scelo GA, Chang JS, Urayama KY, Aldrich MC, et al. Variation in xenobiotic transport and metabolism genes, household chemical exposures, and risk of childhood acute lymphoblastic leukemia. Cancer Causes Control. 2012;23:1367-75.
17. Han S, Koo HH, Lan Q, Lee KM, Park AK, Park SK, et al. Common variation in genes related to immune response and risk of childhood leukemia. Hum Immunol. 2012;73:316-9.
18. Han S, Lan Q, Park AK, Lee KM, Park SK, Ahn HS, et al. Polymorphisms in innate immunity genes and risk of childhood leukemia. Hum Immunol. 2010;71:727-30.
19. Park C, Han S, Lee KM, Choi JY, Song N, Jeon S, et al. Association between CASP7 and CASP14 genetic polymorphisms and the risk of childhood leukemia. Hum Immunol. 2012;73:736-9.
20. Lupo PJ, Nousome D, Kamdar KY, Okcu MF, Scheurer ME. A case-parent triad assessment of folate metabolic genes and the risk of childhood acute lymphoblastic leukemia. Cancer Causes Control. 2012;23:1797-803.
21. Taylor M, Bergemann TL, Hussain A, Thompson PD, Spector L. Transmission of HLA-DP variants from parents to children with B-cell precursor acute lymphoblastic leukemia: log-linear analysis using the case-parent design. Hum Immunol. 2011;72:897-903.
22. Yang Y, Jin X, Yan C, Tian Y, Tang J, Shen X. Case-only study of interactions between DNA repair genes (hMLH1, APEX1, MGMT, XRCC1 and XPD) and low-frequency electromagnetic fields in childhood acute leukemia. Leuk Lymphoma. 2008;49:2344-50.
23. Yang Y, Tian Y, Jin X, Yan C, Jiang F, Zhang Y, et al. A case-only study of interactions between metabolic enzyme polymorphisms and industrial pollution in childhood acute leukemia. Environ Toxicol Pharmacol. 2009;28:161-6.
24. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA. 1997;94:3290-5.
25. Das PM, Singal R. DNA methylation and cancer. J Clin Oncol. 2004;22:4632-42. (Pubitemid 41185132)
26. Wang H, Wang J, Zhao L, Liu X, Mi W. Methylenetetrahydrofolate reductase polymorphisms and risk of acute lymphoblastic leukemia - evidence from an updated meta-analysis including 35 studies. BMC Med Genet. 2012;13:77.
27. Yan J, Yin M, Dreyer ZE, Scheurer ME, Kamdar K, Wei Q, et al. A meta-analysis of MTHFR C677T and A1298C polymorphisms and risk of acute lymphoblastic leukemia in children. Pediatr Blood Cancer. 2012;58:513-8.
28. Zintzaras E, Doxani C, Rodopoulou P, Bakalos G, Ziogas DC, Ziakas P, et al. Variants of the MTHFR gene and susceptibility to acute lymphoblastic leukemia in children: A synthesis of genetic association studies. Cancer Epidemiol. 2012;36:169-76.
29. Amigou A, Rudant J, Orsi L, Goujon-Bellec S, Leverger G, Baruchel A, et al. Folic acid supplementation, MTHFR and MTRR polymorphisms, and the risk of childhood leukemia: the ESCALE study (SFCE). Cancer Causes Control. 2012;23:1265-77.
30. Azhar MR, Rahimi Z, Vaisi-Raygani A, Akramipour R, Madani H, Parsian A. Lack of association between MTHFR C677T and A1298C polymorphisms and risk of childhood acute lymphoblastic leukemia in the Kurdish population from Western Iran. Genet Test Mol Biomarkers. 2012;16:198-202.
31. Metayer C, Scelo G, Chokkalingam AP, Barcellos LF, Aldrich MC, Chang JS, et al. Genetic variants in the folate pathway and risk of childhood acute lymphoblastic leukemia. Cancer Causes Control. 2011;22:1243-58.
32. Nikbakht M, MalekZadeh K, Kumar Jha A, Askari M, Marwaha RK, Kaul D, et al. Polymorphisms of MTHFR and MTR genes are not related to susceptibility to childhood ALL in North India. Exp Oncol. 2012;34:43-8.
33. Krajinovic M, Lamothe S, Labuda D, Lemieux-Blanchard E, Theoret Y, Moghrabi A, et al. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood. 2004;103:252-7. (Pubitemid 38029946)
34. Pereira AC, Schettert IT, Morandini Filho AA, Guerra-Shinohara EM, Krieger JE. Methylenetetrahydrofolate reductase (MTHFR) c677t gene variant modulates the homocysteine folate correlation in a mild folate-deficient population. Clin Chim Acta. 2004;340:99-105. (Pubitemid 38167513)
35. Milne E, de Klerk NH, van Bockxmeer F, Kees UR, Thompson JR, Baker D, et al. Is there a folate-related gene-environment interaction in the etiology of childhood acute lymphoblastic leukemia? Int J Cancer. 2006;119:229-32.
36. Thirumaran RK, Gast A, Flohr T, Burwinkel B, Bartram C, Hemminki K, et al. MTHFR genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Blood. 2005;106:2590-1; author reply 1-2.
37. Chan JY, Ugrasena DG, Lum DW, Lu Y, Yeoh AE. Xenobiotic and folate pathway gene polymorphisms and risk of childhood acute lymphoblastic leukaemia in Javanese children. Hematol Oncol. 2011;29:116-23.
38. Zhao W, Yue LJ, Chen XW. Association of single nucleotide polymorphism of reduced folate carrier gene with susceptibility to acute leukemia. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011;28:446-9.
39. Yeoh AE, Lu Y, Chan JY, Chan YH, Ariffin H, Kham SK, et al. Genetic susceptibility to childhood acute lymphoblastic leukemia shows protection in Malay boys: results from the Malaysia-Singapore ALL Study Group. Leuk Res. 2010;34:276-83.
40. Lightfoot TJ, Johnston WT, Painter D, Simpson J, Roman E, Skibola CF, et al. Genetic variation in the folate metabolic pathway and risk of childhood leukemia. Blood. 2010;115:3923-9.
41. Gast A, Bermejo JL, Flohr T, Stanulla M, Burwinkel B, Schrappe M, et al. Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: A case-control study. Leukemia. 2007;21:320-5. (Pubitemid 46158126)
42. Jamroziak K, Robak T. Do polymorphisms in ABC transporter genes influence risk of childhood acute lymphoblastic leukemia? Leuk Res. 2008;32:1173-5.
43. Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV, et al. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science. 2007;315:525-8. (Pubitemid 46175758)
44. Wang J, Wang B, Bi J, Li K, Di J. MDR1 gene C3435T polymorphism and cancer risk: A meta-analysis of 34 case-control studies. J Cancer Res Clin Oncol. 2012;138:979-89.
45. Zhuo W, Zhang L, Qiu Z, Zhu B, Chen Z. Does cytochrome P450 1A1 MspI polymorphism increase acute lymphoblastic leukemia risk? Evidence from 2013 cases and 2903 controls. Gene. 2012;510:14-21.
46. Swinney RM, Beuten J, Collier AB 3rd, Chen TT, Winick NJ, Pollock BH, et al. Polymorphisms in CYP1A1 and ethnic-specific susceptibility to acute lymphoblastic leukemia in children. Cancer Epidemiol Biomarkers Prev. 2011;20:1537-42.
47. Yamaguti GG, Lourenco GJ, Silveira VS, Tone LG, Lopes LF, Lima CS. Increased risk for acute lymphoblastic leukemia in children with cytochrome P450A1 (CYP1A1)- and NAD(P)H:quinone oxidoreductase 1 (NQO1)-inherited gene variants. Acta Haematol. 2010;124:182-4.
48. Lee KM, Ward MH, Han S, Ahn HS, Kang HJ, Choi HS, et al. Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk. Leuk Res. 2009;33:250-8.
49. Bonaventure A, Goujon-Bellec S, Rudant J, Orsi L, Leverger G, Baruchel A, et al. Maternal smoking during pregnancy, genetic polymorphisms of metabolic enzymes, and childhood acute leukemia: the ESCALE study (SFCE). Cancer Causes Control. 2012;23:329-45.
50. Silveira Vda S, Canalle R, Scrideli CA, Queiroz RG, Tone LG. Role of the CYP2D6, EPHX1, MPO, and NQO1 genes in the susceptibility to acute lymphoblastic leukemia in Brazilian children. Environ Mol Mutagen. 2010;51:48-56.
51. Borst L, Wallerek S, Dalhoff K, Rasmussen KK, Wesenberg F, Wehner PS, et al. The impact of CYP3A53 on risk and prognosis in childhood acute lymphoblastic leukemia. Eur J Haematol. 2011;86:477-83.
52. Pakakasama S, Mukda E, Sasanakul W, Kadegasem P, Udomsubpayakul U, Thithapandha A, et al. Polymorphisms of drug-metabolizing enzymes and risk of childhood acute lymphoblastic leukemia. Am J Hematol. 2005;79:202-5. (Pubitemid 40967075)
53. Silveira VS, Canalle R, Scrideli CA, Queiroz RG, Lopes LF, Tone LG. CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome. Mol Cell Biochem. 2012;364:217-23.
54. Clavel J, Bellec S, Rebouissou S, Menegaux F, Feunteun J, Bonaiti-Pellie C, et al. Childhood leukaemia, polymorphisms of metabolism enzyme genes, and interactions with maternal tobacco, coffee and alcohol consumption during pregnancy. Eur J Cancer Prev. 2005;14:531-40. (Pubitemid 41689653)
55. Tumer TB, Sahin G, Arinc E. Association between polymorphisms of EPHX1 and XRCC1 genes and the risk of childhood acute lymphoblastic leukemia. Arch Toxicol. 2012;86:431-9.
56. Rimando MG, Chua MN, Yuson E, de Castro-Bernas G, Okamoto T. Prevalence of GSTT1, GSTM1 and NQO1 (609C>T) in Filipino children with ALL (acute lymphoblastic leukaemia). Biosci Rep. 2008;28:117-24.
57. Suneetha KJ, Nancy KN, Rajalekshmy KR, Sagar TG, Rajkumar T. Role of GSTM1 (Present/Null) and GSTP1 (Ile105Val) polymorphisms in susceptibility to acute lymphoblastic leukemia among the South Indian population. Asian Pac J Cancer Prev. 2008;9:733-6.
58. Krajinovic M, Richer C, Sinnett H, Labuda D, Sinnett D. Genetic polymorphisms of N-acetyltransferases 1 and 2 and gene-gene interaction in the susceptibility to childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev. 2000;9:557-62. (Pubitemid 30396176)
59. Zanrosso CW, Emerenciano M, Faro A, Goncalves BA, Mansur MB, Pombo-de-Oliveira MS. Genetic variability in N-acetyltransferase 2 gene determines susceptibility to childhood lymphoid or myeloid leukemia in Brazil. Leuk Lymphoma. 2012;53:323-7.
60. de Aguiar Goncalves BA, Vasconcelos GM, Thuler LC, Andrade C, Faro A, Pombo-de-Oliveira MS. NQO1 rs1800566 (C609T), PON1 rs662 (Q192R), and PON1 rs854560 (L55M) polymorphisms segregate the risk of childhood acute leukemias according to age range distribution. Cancer Causes Control. 2012;23:1811-9.
61. Guha N, Chang JS, Chokkalingam AP, Wiemels JL, Smith MT, Buffler PA. NQO1 polymorphisms and de novo childhood leukemia: A HuGE review and meta-analysis. Am J Epidemiol. 2008;168:1221-32.
62. Gillert E, Leis T, Repp R, Reichel M, Hosch A, Breitenlohner I, et al. A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cells. Oncogene. 1999;18:4663-71. (Pubitemid 29417741)
63. Lindahl T, Wood RD. Quality control by DNA repair. Science. 1999;286:1897-905. (Pubitemid 129515891)
64. Wang L, Yin F, Xu X, Hu X, Zhao D. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and risk of childhood acute lymphoblastic leukemia: A meta-analysis. PLoS One. 2012;7:e34897.
65. Wang R, Hu X, Zhou Y, Feng Q, Su L, Long J, et al. XRCC1 Arg399Gln and Arg194Trp polymorphisms in childhood acute lymphoblastic leukemia risk: A meta-analysis. Leuk Lymphoma. 2012;PMID: 22712837.
66. Canalle R, Silveira VS, Scrideli CA, Queiroz RG, Lopes LF, Tone LG. Impact of thymidylate synthase promoter and DNA repair gene polymorphisms on susceptibility to childhood acute lymphoblastic leukemia. Leuk Lymphoma. 2011;52:1118-26.
67. McNally RJ, Eden TO. An infectious aetiology for childhood acute leukaemia: A review of the evidence. Br J Haematol. 2004;127:243-63. (Pubitemid 39468939)
68. Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer. 2006;6(3):193-203. (Pubitemid 43292563)
69. Shiina T, Inoko H, Kulski JK. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens. 2004;64:631-49. (Pubitemid 39628044)
70. Dorak MT, Oguz FS, Yalman N, Diler AS, Kalayoglu S, Anak S, et al. A male-specific increase in the HLA-DRB4 (DR53) frequency in high-risk and relapsed childhood ALL. Leuk Res. 2002;26:651-6. (Pubitemid 34465701)
71. Dorak MT, Lawson T, Machulla HK, Darke C, Mills KI, Burnett AK. Unravelling an HLA-DR association in childhood acute lymphoblastic leukemia. Blood. 1999;94:694-700. (Pubitemid 29323883)
72. Yari F, Sobhani M, Sabaghi F, Zaman-Vaziri M, Bagheri N, Talebian A. Frequencies of HLA-DRB1 in Iranian normal population and in patients with acute lymphoblastic leukemia. Arch Med Res. 2008;39:205-8. (Pubitemid 350299626)
73. Klitz W, Gragert L, Trachtenberg E. Spectrum of HLA associations: the case of medically refractory pediatric acute lymphoblastic leukemia. Immunogenetics. 2012;64:409-19.
74. Morrison BA, Ucisik-Akkaya E, Flores H, Alaez C, Gorodezky C, Dorak MT. Multiple sclerosis risk markers in HLA-DRA, HLA-C, and IFNG genes are associated with sex-specific childhood leukemia risk. Autoimmunity. 2010;43:690-7.
75. Wang XJ, Ai XF, Sun HY, Wang F, Xu SC, Gui FM, et al. Relation of HLA-DRB115 with pathogenesis in 162 childhood cases of acute lymphoblastic leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009;17:1507-10.
76. Taylor GM, Dearden S, Ravetto P, Ayres M, Watson P, Hussain A, et al. Genetic susceptibility to childhood common acute lymphoblastic leukaemia is associated with polymorphic peptide-binding pocket profiles in HLA-DPB10201. Hum Mol Genet. 2002;11:1585-97. (Pubitemid 34812254)
77. Taylor GM, Robinson MD, Binchy A. Preliminary evidence of an association between HLA-DPB10201 and childhood acute lymphobastic leukemia supports an infectious aetiology. Leukemia. 1995;9:440-3.
78. Urayama KY, Chokkalingam AP, Metayer C, Ma X, Selvin S, Barcellos LF, et al. HLA-DP genetic variation, proxies for early life immune modulation and childhood acute lymphoblastic leukemia risk. Blood. 2012;120:3039-47.
79. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, Price A, Olver B, Sheridan E, et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet. 2009;41:1006-10.
80. Trevino LR, Yang W, French D, Hunger SP, Carroll WL, Devidas M, et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet. 2009;41:1001-5.
81. Pastorczak A, Gorniak P, Sherborne A, Hosking F, Trelinska J, Lejman M, et al. Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population. Leuk Res. 2011;35:1534-6.
82. Prasad RB, Hosking FJ, Vijayakrishnan J, Papaemmanuil E, Koehler R, Greaves M, et al. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood. 2010;115:1765-7.
83. Vijayakrishnan J, Sherborne AL, Sawangpanich R, Hongeng S, Houlston RS, Pakakasama S. Variation at 7p12.2 and 10q21.2 influences childhood acute lymphoblastic leukemia risk in the Thai population and may contribute to racial differences in leukemia incidence. Leuk Lymphoma. 2010;51:1870-4.
84. Ross JA, Linabery AM, Blommer CN, Langer EK, Spector LG, Hilden JM, et al. Genetic variants modify susceptibility to leukemia in infants: A Children's Oncology Group report. Pediatr Blood Cancer. 2012 doi: 10.1002/pbc.24131.
85. Healy J, Richer C, Bourgey M, Kritikou EA, Sinnett D. Replication analysis confirms the association of ARID5B with childhood B-cell acute lymphoblastic leukemia. Haematologica. 2010;95:1608-11.
86. Yang W, Trevino LR, Yang JJ, Scheet P, Pui CH, Evans WE, et al. ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidence. Leukemia. 2010;24:894-6.
87. Sherborne AL, Hosking FJ, Prasad RB, Kumar R, Koehler R, Vijayakrishnan J, et al. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet. 2010;42:492-4.
88. Ellinghaus E, Stanulla M, Richter G, Ellinghaus D, te Kronnie G, Cario G, et al. Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia. Leukemia. 2012;26:902-9.
89. Orsi L, Rudant J, Bonaventure A, Goujon-Bellec S, Corda E, Evans TJ, et al. Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE). Leukemia. 2012 doi: 10.1038/leu.2012.148.
90. Han S, Lee KM, Park SK, Lee JE, Ahn HS, Shin HY, et al. Genome-wide association study of childhood acute lymphoblastic leukemia in Korea. Leuk Res. 2010;34:1271-4.
91. Georgopoulos K, Bigby M, Wang JH, Molnar A, Wu P, Winandy S, et al. The Ikaros gene is required for the development of all lymphoid lineages. Cell. 1994;79:143-56. (Pubitemid 24309520)
92. Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, Ma J, et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature. 2008;453:110-4. (Pubitemid 351630327)
93. Mullighan CG, Su X, Zhang J, Radtke I, Phillips LA, Miller CB, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med. 2009;360:470-80.
94. Lahoud MH, Ristevski S, Venter DJ, Jermiin LS, Bertoncello I, Zavarsek S, et al. Gene targeting of Desrt, a novel ARID class DNA-binding protein, causes growth retardation and abnormal development of reproductive organs. Genome Res. 2001;11:1327-34. (Pubitemid 32771539)
95. Chang LW, Payton JE, Yuan W, Ley TJ, Nagarajan R, Stormo GD. Computational identification of the normal and perturbed genetic networks involved in myeloid differentiation and acute promyelocytic leukemia. Genome Biol. 2008;9:R38.
96. Akasaka T, Balasas T, Russell LJ, Sugimoto KJ, Majid A, Walewska R, et al. Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood. 2007;109:3451-61. (Pubitemid 46572535)
97. Mullighan CG, Downing JR. Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions. Leukemia. 2009;23:1209-18.
98. Zhu JW, Brdicka T, Katsumoto TR, Lin J, Weiss A. Structurally distinct phosphatases CD45 and CD148 both regulate B cell and macrophage immunoreceptor signaling. Immunity. 2008;28:183-96.
99. Almalte Z, Samarani S, Iannello A, Debbeche O, Duval M, Infante-Rivard C, et al. Novel associations between activating killer-cell immunoglobulin-like receptor genes and childhood leukemia. Blood. 2011;118:1323-8.
100. Hosking FJ, Leslie S, Dilthey A, Moutsianas L, Wang Y, Dobbins SE, et al. MHC variation and risk of childhood B-cell precursor acute lymphoblastic leukemia. Blood. 2011;117:1633-40.
101. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661-78.
102. Lee SH, Wray NR, Goddard ME, Visscher PM. Estimating missing heritability for disease from genome-wide association studies. Am J Hum Genet. 2011;88:294-305.
103. Yang J, Benyamin B, McEvoy BP, Gordon S, Henders AK, Nyholt DR, et al. Common SNPs explain a large proportion of the heritability for human height. Nat Genet. 2010;42:565-9.
104. Sherborne AL, Hemminki K, Kumar R, Bartram CR, Stanulla M, Schrappe M, et al. Rationale for an international consortium to study inherited genetic susceptibility to childhood acute lymphoblastic leukemia. Haematologica. 2011;96:1049-54.
105. Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, Thomas G, et al. Replicating genotype-phenotype associations. Nature. 2007;447:655-60. (Pubitemid 46889722)
106. Mukherjee B, Ahn J, Gruber SB, Chatterjee N. Testing gene-environment interaction in large-scale case-control association studies: possible choices and comparisons. Am J Epidemiol. 2012;175:177-90.
107. Freedman ML, Monteiro AN, Gayther SA, Coetzee GA, Risch A, Plass C, et al. Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet. 2011;43:513-8.
108. Genomes Project Consortium. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56-65.
109. Su Z, Ning B, Fang H, Hong H, Perkins R, Tong W, et al. Next-generation sequencing and its applications in molecular diagnostics. Expert Rev Mol Diagn. 2011;11:333-43.
110. Cheung VG, Spielman RS. Genetics of human gene expression: mapping DNA variants that influence gene expression. Nat Rev Genet. 2009;10:595-604.
111. Yang TP, Beazley C, Montgomery SB, Dimas AS, Gutierrez-Arcelus M, Stranger BE, et al. Genevar: A database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies. Bioinformatics. 2010;26:2474-6.
112. Hogan LE, Meyer JA, Yang J, Wang J, Wong N, Yang W, et al. Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. Blood. 2011;118:5218-26.
113. Rahimi Z, Ahmadian Z, Akramipour R, Vaisi-Raygani A, Parsian A (2012) Thymidylate synthase and methionine synthase polymorphisms are not associated with susceptibility to childhood acute lymphoblastic leukemia in Kurdish population from Western Iran. Mol Biol Rep 39(3):2195-2200